By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

BioCardia, Inc. 

384 Oyster Point Boulevard, #4

South San Francisco  California  94080  U.S.A.
Phone: 650-624-0120 Fax: 650-624-0125


SEARCH JOBS


Industry
Biotechnology






Company News
BioCardia’s CardiAMP Heart Failure Trial Design To Be Presented At Texas Heart Institute International Symposium On Cardiovascular Regenerative Medicine 9/15/2017 7:22:48 AM
BioCardia Receives U.S. Patent Covering A Method Of Preparing And Characterizing Mesenchymal Cells, Providing Further Protection To Cardiallo Cell Therapy Program 9/7/2017 6:36:27 AM
BioCardia Completes Roll-In Cohort In Pivotal Phase III CardiAMP Heart Failure Trial 7/26/2017 8:16:43 AM
BioCardia Release: Study Shows Helix Transendocardial Delivery System Enables Greater Myocardial Retention Of Stem Cell Therapy 5/25/2017 7:06:51 AM
Johns Hopkins Medicine, Maryland Stem Cell Research Fund And BioCardia Announce First Patient Treated With CardiAMP Cell Therapy For Ischemic Heart Failure In Phase III Clinical Trial 2/28/2017 7:31:01 AM
BioCardia Release: CardiAMP Pivotal Heart Failure Trial Initiated At Two US Centers 12/29/2016 8:17:04 AM
BioCardia Receives Another U.S. Patent Covering A Method Of Treating Heart Attack Tissue Damage With A Patient’s Own Progenitor Cells, Providing Further Protection To Phase III CardiAMP Program 12/27/2016 10:38:36 AM
BioCardia Receives U.S. Patent Covering A Method Of Treating Heart Attack Tissue Damage With A Patient’s Own Progenitor Cells, Providing Further Protection To Phase III Cardiamp Program 12/14/2016 7:34:08 AM
BioCardia Closes Merger With Tiger X Medical 10/24/2016 12:54:37 PM
BioCardia Signs Merger Agreement With Tiger X Medical Secures Funding To Support Further Development Of Cardiamp Cell Therapy System For The Treatment Of Heart Failure 8/23/2016 10:44:15 AM
123
//-->